Report Detail
Global Substance Use Disorders (SUDs) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3713464 |
- 30 August, 2019 |
- Global |
- 115 Pages |
- GIR (Global Info Research) |
- Other
A substance use disorder (SUD), also known as a drug use disorder, is a medical condition in which the use of one or more substances leads to a clinically significant impairment or distress. Theres is habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of SUD. Some commonly used drug for treatment of SUD are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Scope of the Report:
The global Substance Use Disorders (SUDs) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Substance Use Disorders (SUDs) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Substance Use Disorders (SUDs) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Substance Use Disorders (SUDs) Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Market Segment by Applications, can be divided into
Hospital & Clinics
Residential (non-hospital)
Table of Contents
1 Substance Use Disorders (SUDs) Treatment Market Overview
- 1.1 Product Overview and Scope of Substance Use Disorders (SUDs) Treatment
- 1.2 Classification of Substance Use Disorders (SUDs) Treatment by Types
- 1.2.1 Global Substance Use Disorders (SUDs) Treatment Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Types in 2018
- 1.2.3 Opioid Addiction
- 1.2.4 Tobacco/Nicotine Addiction
- 1.2.5 Alcohol Dependence
- 1.3 Global Substance Use Disorders (SUDs) Treatment Market by Application
- 1.3.1 Global Substance Use Disorders (SUDs) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital & Clinics
- 1.3.3 Residential (non-hospital)
- 1.4 Global Substance Use Disorders (SUDs) Treatment Market by Regions
- 1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
- 1.5 Global Market Size of Substance Use Disorders (SUDs) Treatment (2014-2024)
2 Manufacturers Profiles
- 2.1 Indivior
- 2.1.1 Business Overview
- 2.1.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Indivior Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Pfizer
- 2.2.1 Business Overview
- 2.2.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Pfizer Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Alkermes
- 2.3.1 Business Overview
- 2.3.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Alkermes Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Novartis
- 2.4.1 Business Overview
- 2.4.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Novartis Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Mylan
- 2.5.1 Business Overview
- 2.5.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Mylan Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Cipla
- 2.6.1 Business Overview
- 2.6.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Cipla Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Glenmark
- 2.7.1 Business Overview
- 2.7.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Glenmark Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 Dr. Reddy's Laboratories
- 2.8.1 Business Overview
- 2.8.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 Teva Pharmaceutical
- 2.9.1 Business Overview
- 2.9.2 Substance Use Disorders (SUDs) Treatment Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Substance Use Disorders (SUDs) Treatment Market Competition, by Players
- 3.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Substance Use Disorders (SUDs) Treatment Players Market Share
- 3.2.2 Top 10 Substance Use Disorders (SUDs) Treatment Players Market Share
- 3.3 Market Competition Trend
4 Global Substance Use Disorders (SUDs) Treatment Market Size by Regions
- 4.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Regions
- 4.2 North America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 4.3 Europe Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 4.5 South America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
5 North America Substance Use Disorders (SUDs) Treatment Revenue by Countries
- 5.1 North America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
- 5.2 USA Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 5.3 Canada Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Substance Use Disorders (SUDs) Treatment Revenue by Countries
- 6.1 Europe Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
- 6.2 Germany Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 6.3 UK Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 6.4 France Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 6.5 Russia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 6.6 Italy Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue by Countries
- 7.1 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
- 7.2 China Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 7.3 Japan Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 7.4 Korea Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 7.5 India Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
8 South America Substance Use Disorders (SUDs) Treatment Revenue by Countries
- 8.1 South America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
- 8.2 Brazil Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Substance Use Disorders (SUDs) Treatment by Countries
- 9.1 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 9.3 UAE Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
10 Global Substance Use Disorders (SUDs) Treatment Market Segment by Type
- 10.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Type (2014-2019)
- 10.2 Global Substance Use Disorders (SUDs) Treatment Market Forecast by Type (2019-2024)
- 10.3 Opioid Addiction Revenue Growth Rate (2014-2024)
- 10.4 Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2024)
- 10.5 Alcohol Dependence Revenue Growth Rate (2014-2024)
11 Global Substance Use Disorders (SUDs) Treatment Market Segment by Application
- 11.1 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Application (2014-2019)
- 11.2 Substance Use Disorders (SUDs) Treatment Market Forecast by Application (2019-2024)
- 11.3 Hospital & Clinics Revenue Growth (2014-2019)
- 11.4 Residential (non-hospital) Revenue Growth (2014-2019)
12 Global Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2024)
- 12.1 Global Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2024)
- 12.2 Global Substance Use Disorders (SUDs) Treatment Market Forecast by Regions (2019-2024)
- 12.3 North America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
- 12.4 Europe Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
- 12.6 South America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Substance Use Disorders (SUDs) Treatment. Industry analysis & Market Report on Substance Use Disorders (SUDs) Treatment is a syndicated market report, published as Global Substance Use Disorders (SUDs) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Substance Use Disorders (SUDs) Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
